<DOC>
	<DOC>NCT00963469</DOC>
	<brief_summary>This is a study to evaluate the treatment effect of montelukast 10 mg taken in the morning, versus placebo, in patients with seasonal allergic rhinitis. Loratadine is included in the study as an active control.</brief_summary>
	<brief_title>Montelukast in Seasonal Allergic Rhinitis: Fall 2001 Study (0476-240)</brief_title>
	<detailed_description />
	<mesh_term>Rhinitis, Allergic</mesh_term>
	<mesh_term>Rhinitis</mesh_term>
	<mesh_term>Rhinitis, Allergic, Seasonal</mesh_term>
	<mesh_term>Montelukast</mesh_term>
	<mesh_term>Loratadine</mesh_term>
	<criteria>Patient has a history of seasonal allergic rhinitis that worsens during the study season Patient is a nonsmoker Patient is in good health physical and mental health Patient is hospitalized Patient is a woman who is &lt; 8 weeks postpartum or is breastfeeding Patient plans to move or vacation away during the study Patient has had any major surgery with in past 4 weeks Patient is a current or past abuser of alcohol or illicit drugs</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>June 2015</verification_date>
</DOC>